Effect of cytosine arabinoside metabolizing enzyme expression on drug toxicity in acute myeloid leukemia
- 13 November 2014
- journal article
- letter
- Published by Springer Science and Business Media LLC in Annals of Hematology
- Vol. 94 (5), 883-885
- https://doi.org/10.1007/s00277-014-2254-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cytidine Deaminase Genetic Variants Influence RNA Expression and Cytarabine Cytotoxicity in Acute Myeloid LeukemiaPharmacogenomics, 2012
- Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based ChemotherapiesJournal of Clinical Oncology, 2010
- Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemiaBritish Journal of Haematology, 2009
- Optimal induction and post-remission therapy for AML in first remissionHematology, 2009
- Pediatric acute myeloid leukemia: towards high-quality cure of all patientsHaematologica, 2007
- Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase downregulationPharmacogenetics and Genomics, 2007
- Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patientsHaematologica, 2007
- Deoxycytidine kinase and cN‐II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabineBritish Journal of Haematology, 2003
- Cytidine deaminase - the methodological relevance of AraC deamination for ex vivo experiments using cultured cell lines, fresh leukemic blasts, and normal bone marrow cellsAnnals of Hematology, 1999
- The lethality of aranucleotides.1976